Drug intelligence / Profile preview

fish oil (Melbourne Health)

Development stage
Approved
Lead developer
BASF
Modality
Small Molecules
Administration
Oral
01

Overview

Fish oil-Melbourne Health refers to a high-dose omega-3 polyunsaturated fatty acid supplementation regimen (6 g/day) evaluated by Melbourne Health in a Phase 4 clinical trial. The intervention consists of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are naturally derived small molecules classified as nutraceuticals. The study specifically investigated the efficacy of these supplements in preventing atrial mechanical stunning and structural remodeling in patients with persistent atrial fibrillation or atrial flutter following electrical cardioversion. Mechanistically, omega-3 fatty acids incorporate into cardiac cell membranes, where they exert anti-inflammatory, autonomic, and electrophysiological effects that may stabilize the atrial myocardium and reduce the recurrence of arrhythmias.

Brand names
OmacorLovazaVascepaEpanova
Other names
omega-3 polyunsaturated fatty acidsomega3 polyunsaturated fatty acidsomega 3 polyunsaturated fatty acidsomega-3 fatty acidsomega3 fatty acidsomega 3 fatty acidseicosapentaenoic aciddocosahexaenoic acidEPADHA

Beyond the preview

Go deeper on fish oil (Melbourne Health).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fish oil (Melbourne Health).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call